The state’s insulin — sold under the brand name CalRx — will be available at a recommended price of $11 per pen, or $55 for a ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major ...

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled ...

The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.

As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom today announced that CalRx® ...

California will offer CalRx-branded biosimilar insulin glargine pens for $11 per pen beginning January 1, 2026.

California introduces CalRx insulin at $55 for a five-pack, making it affordable and available by 2026 through a state ...

California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell ...